-
1 . Academic Journal
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial.
- 저자
- by Fuente, Macarena I de la; Colman, Howard; Rosenthal, Mark; Tine, Brian A Van; Levacic, Danijela, et al.
- 소스
- Neuro-Oncology; Jan2023, Vol. 25 Issue 1, p146-156, 11p